Transarterial chemoebolization (TACE) of liver metastases derived from neuroendocrine tumors is an effective treatment only in patients with low or mediate hepatic tumor burden

#109

Introduction: The onset of metastases in patients with neuroendocrine tumors of the gastrointestinal tract (GEP-NET) represents a negative predictor of survival and tumor-associated complications. Thereby, most of these patients develop liver metastases during their disease. Transarterial chemoembolization (TACE) has been shown before to be an effective and safe treatment of liver metastases. However, the optimal time point in treatment of liver metastases has not yet been determined, especially in patients with non-functional GEP-NET.

Aim(s): To evaluate the effectivness of TACE in a large single center.

Materials and methods: In the present work, we show the results of a single center study of 265 TACE in 72 patients with liver metastases of GEP-NET between 2002 and 2009.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Rinke A, König A, Müller D, König U, Gress T,

Keywords: neuroendocrine tumor, chemoembolization, tumor burden,